| abstract |
The present disclosure provides antibodies that specifically bind to ApoC3 (eg, human ApoC3) and antagonize the function of ApoC3. Also provided are pharmaceutical compositions comprising the antibodies, nucleic acids encoding the antibodies, expression vectors and host cells for producing the antibodies, and methods of treating a subject using the antibodies. |